|  Help  |  About  |  Contact Us

Publication : Protection from experimental asthma by an endogenous bronchodilator.

First Author  Que LG Year  2005
Journal  Science Volume  308
Issue  5728 Pages  1618-21
PubMed ID  15919956 Mgi Jnum  J:105651
Mgi Id  MGI:3616157 Doi  10.1126/science.1108228
Citation  Que LG, et al. (2005) Protection from experimental asthma by an endogenous bronchodilator. Science 308(5728):1618-21
abstractText  Mechanisms that protect against asthma remain poorly understood. S-nitrosoglutathione (GSNO), an endogenous bronchodilator, is depleted from asthmatic airways, suggesting a protective role. We report that, following allergen challenge, wild-type mice exhibiting airway hyperresponsivity have increased airway levels of the enzyme GSNO reductase (GSNOR) and are depleted of lung S-nitrosothiols (SNOs). In contrast, mice with genetic deletion of GSNOR exhibit increases in lung SNOs and are protected from airway hyperresponsivity. Our results indicate that endogenous SNOs, governed by GSNOR, are critical regulators of airway responsivity and may provide new therapeutic approaches to asthma.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression